IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,435,332 | -17.0% | 759,833 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $47,493,357 | +23.5% | 792,084 | +1.8% | 0.00% | 0.0% |
| Q1 2023 | $38,460,661 | -14.6% | 777,926 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $45,027,944 | +92.1% | 788,995 | +58.0% | 0.00% | 0.0% |
| Q3 2022 | $23,444,000 | +26.6% | 499,432 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $18,513,000 | +24.8% | 496,182 | 0.0% | 0.00% | – |
| Q1 2022 | $14,836,000 | -12.7% | 496,182 | 0.0% | 0.00% | – |
| Q4 2021 | $16,990,000 | -44.6% | 496,182 | -40.0% | 0.00% | -100.0% |
| Q3 2021 | $30,680,000 | -27.2% | 827,604 | -23.4% | 0.00% | 0.0% |
| Q2 2021 | $42,170,000 | -8.3% | 1,079,926 | -0.0% | 0.00% | 0.0% |
| Q1 2021 | $45,981,000 | – | 1,080,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $29,942,304 | 35.70% |
| RTW INVESTMENTS, LP | 6,096,387 | $316,402,485 | 6.68% |
| Paradigm Biocapital Advisors LP | 1,384,686 | $71,865,203 | 4.88% |
| Rock Springs Capital Management LP | 2,943,710 | $152,778,549 | 4.09% |
| Logos Global Management LP | 450,000 | $23,355,000 | 3.12% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $21,050,640 | 2.97% |
| GREAT POINT PARTNERS LLC | 290,917 | $15,098,592 | 2.75% |
| Nicholas Investment Partners, LP | 512,855 | $26,617,175 | 1.99% |
| Eschler Asset Management LLP | 30,000 | $1,557,000 | 1.82% |
| COWEN AND COMPANY, LLC | 460,036 | $23,875,868 | 1.67% |